NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 32 filers reported holding NOVOCURE LTD in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,074,016 | -68.6% | 4,750,000 | -68.3% | 0.18% | -58.4% |
| Q1 2023 | $12,980,000 | +16.9% | 15,000,000 | +20.0% | 0.44% | +27.1% |
| Q4 2022 | $11,103,750 | -24.5% | 12,500,000 | -24.2% | 0.35% | -23.4% |
| Q3 2022 | $14,708,000 | +9.2% | 16,500,000 | +6.5% | 0.46% | +6.8% |
| Q2 2022 | $13,466,000 | +47.6% | 15,500,000 | +55.0% | 0.43% | +112.9% |
| Q1 2022 | $9,125,000 | – | 10,000,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 134,334,000 | $116,802,148 | 3.85% |
| STEELHEAD PARTNERS LLC | 46,562,000 | $40,485,659 | 2.64% |
| DeepCurrents Investment Group LLC | 40,000,000 | $34,578,496 | 1.35% |
| WOLVERINE ASSET MANAGEMENT LLC | 76,557,000 | $66,300,852 | 0.78% |
| SHENKMAN CAPITAL MANAGEMENT INC | 11,317,000 | $9,786,521 | 0.74% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,856,000 | $4,199,900 | 0.62% |
| Ionic Capital Management LLC | 2,000,000 | $1,726,349 | 0.50% |
| Empyrean Capital Partners, LP | 15,000,000 | $12,980,000 | 0.44% |
| Context Capital Management, LLC | 4,489 | $3,903 | 0.33% |
| Graham Capital Management, L.P. | 11,422,000 | $9,875,746 | 0.30% |